Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03220841Phase 4Unknown

Stricture Definition and Treatment (STRIDENT) Drug Therapy Study

Role: collaborator

NCT03222011Not ApplicableUnknown

Stricture Definition and Treatment (STRIDENT) Endoscopic Therapy Study

Role: collaborator

NCT03218202Terminated

Stricture Definition and Treatment (STRIDENT) Observational Study.

Role: collaborator

All 3 trials loaded